These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31659525)

  • 1. AAZTA
    Sinnes JP; Nagel J; Rösch F
    EJNMMI Radiopharm Chem; 2019 Aug; 4(1):18. PubMed ID: 31659525
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Sinnes JP; Bauder-Wüst U; Schäfer M; Moon ES; Kopka K; Rösch F
    EJNMMI Radiopharm Chem; 2020 Nov; 5(1):28. PubMed ID: 33242189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAZTA
    Klasen B; Moon ES; Rösch F
    Nucl Med Biol; 2021; 96-97():80-93. PubMed ID: 33839678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue.
    Pfister J; Summer D; Rangger C; Petrik M; von Guggenberg E; Minazzi P; Giovenzana GB; Aloj L; Decristoforo C
    EJNMMI Res; 2015 Dec; 5(1):74. PubMed ID: 26669693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Nock BA; Kanellopoulos P; Moon ES; Rouchota M; Loudos G; Ballal S; Yadav MP; Bal C; Mishra P; Sheokand P; Roesch F; Maina T
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the versatile bifunctional chelator AAZTA
    Hofstetter M; Moon ES; D'Angelo F; Geissbühler L; Alberts I; Afshar-Oromieh A; Rösch F; Rominger A; Gourni E
    EJNMMI Radiopharm Chem; 2020 Nov; 5(1):29. PubMed ID: 33258012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of potential PET radiotracers.
    Orteca G; Sinnes JP; Rubagotti S; Iori M; Capponi PC; Piel M; Rösch F; Ferrari E; Asti M
    J Inorg Biochem; 2020 Mar; 204():110954. PubMed ID: 31838188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA
    Moon ES; Van Rymenant Y; Battan S; De Loose J; Bracke A; Van der Veken P; De Meester I; Rösch F
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34201111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach.
    Lahnif H; Grus T; Pektor S; Greifenstein L; Schreckenberger M; Rösch F
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAZTA-Like Ligands Bearing Phenolate Arms as Efficient Chelators for
    Martinelli J; Zapelli LM; Boccalon M; Vágner A; Nagy G; Fekete A; Szikra D; Trencsényi G; Baranyai Z; Tei L
    Chemistry; 2023 Apr; 29(21):e202203798. PubMed ID: 36719326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAZTA: An Ideal Chelating Agent for the Development of
    Nagy G; Szikra D; Trencsényi G; Fekete A; Garai I; Giani AM; Negri R; Masciocchi N; Maiocchi A; Uggeri F; Tóth I; Aime S; Giovenzana GB; Baranyai Z
    Angew Chem Int Ed Engl; 2017 Feb; 56(8):2118-2122. PubMed ID: 28097756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, radiolabeling, and pre-clinical evaluation of [
    Ghiani S; Hawala I; Szikra D; Trencsényi G; Baranyai Z; Nagy G; Vágner A; Stefania R; Pandey S; Maiocchi A
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2351-2362. PubMed ID: 33420915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DATATOC: a novel conjugate for kit-type
    Seemann J; Waldron B; Parker D; Roesch F
    EJNMMI Radiopharm Chem; 2017; 1(1):4. PubMed ID: 29564381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications.
    Fersing C; Masurier N; Rubira L; Deshayes E; Lisowski V
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Instant kit preparation of
    Sinnes JP; Nagel J; Waldron BP; Maina T; Nock BA; Bergmann RK; Ullrich M; Pietzsch J; Bachmann M; Baum RP; Rösch F
    EJNMMI Res; 2019 May; 9(1):48. PubMed ID: 31123943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of novel macrocyclic chelates on the targeting properties of the
    Wang Y; Yuan H; Tang S; Liu Y; Cai P; Liu N; Chen Y; Zhou Z
    EJNMMI Res; 2023 Jun; 13(1):56. PubMed ID: 37285007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equilibrium and kinetic properties of the lanthanoids(III) and various divalent metal complexes of the heptadentate ligand AAZTA.
    Baranyai Z; Uggeri F; Giovenzana GB; Bényei A; Brücher E; Aime S
    Chemistry; 2009; 15(7):1696-705. PubMed ID: 19130509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and stability of hexadentate complexes of ligands based on AAZTA for efficient PET labelling with gallium-68.
    Waldron BP; Parker D; Burchardt C; Yufit DS; Zimny M; Roesch F
    Chem Commun (Camb); 2013 Jan; 49(6):579-81. PubMed ID: 23212712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
    Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
    Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.